Juno Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Seattle, WA USA
Total Funding:$310M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Juno Therapeutics's estimated annual revenue is currently $192.7M per year.(?)
  • Juno Therapeutics's estimated revenue per employee is $155,000
  • Juno Therapeutics's total funding is $310M.

Employee Data

  • Juno Therapeutics has 1243 Employees.(?)
  • Juno Therapeutics currently has 1 job openings.

Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.

keywords:Biotechnology, Healthcare, Health and Wellness